Medicines Evidence Commentary : Cardiovascular disease: statins for primary prevention in older people, with and without diabetes

Source:
National Institute for Health and Care Excellence - NICE
Publisher:
National Institute for Health and Care Excellence (NICE)
Publication date:
10 December 2018

Abstract

A Spanish observational study assessed the benefit of starting statin therapy for primary prevention in participants aged 75 years and older. A statistically significant reduction in cardiovascular disease (CVD) and all-cause mortality was observed in participants aged 75-84 years with type 2 diabetes, but not in people without diabetes or older than this. NICE guidance and patient decision aids support shared decision-making between people and their health professional about whether to start taking a statin.

This link will take you to the medicines evidence commentary featured in the NICE Medicines Awareness Weekly. Medicines evidence commentaries help contextualise important new evidence, highlighting areas that could signal a change in clinical practice. It does not constitute formal NICE guidance.